Your browser doesn't support javascript.
loading
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma.
Weilemann, Andre; Grau, Michael; Erdmann, Tabea; Merkel, Olaf; Sobhiafshar, Ulduz; Anagnostopoulos, Ioannis; Hummel, Michael; Siegert, Antje; Hayford, Claudia; Madle, Hannelore; Wollert-Wulf, Brigitte; Fichtner, Iduna; Dörken, Bernd; Dirnhofer, Stephan; Mathas, Stephan; Janz, Martin; Emre, N C Tolga; Rosenwald, Andreas; Ott, German; Lenz, Peter; Tzankov, Alexandar; Lenz, Georg.
Afiliación
  • Weilemann A; Department of Medicine A, Translational Oncology, Albert-Schweitzer Campus 1, University Hospital Münster, Münster, Germany; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Cells in Motion Cluster of Excellence, Münster, Germany; Mathe
  • Grau M; Department of Physics, Philipps-University, Marburg, Germany;
  • Erdmann T; Department of Medicine A, Translational Oncology, Albert-Schweitzer Campus 1, University Hospital Münster, Münster, Germany; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Cells in Motion Cluster of Excellence, Münster, Germany;
  • Merkel O; Department of Experimental Pathology, Medical University Vienna, Wien, Austria;
  • Sobhiafshar U; Department of Molecular Biology and Genetics, Bogaziçi University, Bebek, Istanbul, Turkey;
  • Anagnostopoulos I; Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany;
  • Hummel M; Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany;
  • Siegert A; Experimental Pharmacology & Oncology Berlin-Buch GmbH, Berlin, Germany;
  • Hayford C; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany;
  • Madle H; Department of Medicine A, Translational Oncology, Albert-Schweitzer Campus 1, University Hospital Münster, Münster, Germany; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Cells in Motion Cluster of Excellence, Münster, Germany;
  • Wollert-Wulf B; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany;
  • Fichtner I; Experimental Pharmacology & Oncology Berlin-Buch GmbH, Berlin, Germany;
  • Dörken B; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany;
  • Dirnhofer S; Institute of Pathology, University Hospital, Basel, Switzerland;
  • Mathas S; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany;
  • Janz M; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany;
  • Emre NC; Department of Molecular Biology and Genetics, Bogaziçi University, Bebek, Istanbul, Turkey;
  • Rosenwald A; Department of Pathology, University of Würzburg, Würzburg, Germany; and.
  • Ott G; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.
  • Lenz P; Department of Physics, Philipps-University, Marburg, Germany;
  • Tzankov A; Institute of Pathology, University Hospital, Basel, Switzerland;
  • Lenz G; Department of Medicine A, Translational Oncology, Albert-Schweitzer Campus 1, University Hospital Münster, Münster, Germany; Department of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Cells in Motion Cluster of Excellence, Münster, Germany;
Blood ; 125(1): 124-32, 2015 Jan 01.
Article en En | MEDLINE | ID: mdl-25359993
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Proteínas Proto-Oncogénicas c-myc / Linfoma Anaplásico de Células Grandes / Factores Reguladores del Interferón Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Proteínas Proto-Oncogénicas c-myc / Linfoma Anaplásico de Células Grandes / Factores Reguladores del Interferón Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Blood Año: 2015 Tipo del documento: Article